Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

Bengaluru: The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...

WASHINGTON — The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...

Analyzer and sampling system engineers in search of a flow switch/monitor that is approved for use in hazardous locations will be interested to learn that the ModelFS10A Analyzer Flow Switch/Monitor ...

Flow Neuroscience's FL-100 headset, using transcranial direct current stimulation for at-home depression treatment, has FDA approval for major depressive disorder. Available in the US by late 2026 ...